Effects of Probucol on plasma amyloid-β transport in patients with hyperlipidemia: a 12-week randomized, double-blind, placebo-controlled trial
This study was registered on the Chinese Clinical Trial Registry platform in June 2019 (Trial registration number: ChiCTR-1900023542).
Authors
- Yi Zhao (ORCID: https://orcid.org/0000-0001-6046-8420)
- Suhang Shang (ORCID: https://orcid.org/0000-0002-0896-204X)
- Rong Zhou (ORCID: https://orcid.org/0000-0003-4018-381X)
- Liangjun Dang (ORCID: https://orcid.org/0009-0001-5100-412X)
- Jingyi Wang (ORCID: https://orcid.org/0000-0003-0465-6253)
- Jin Wang (ORCID: https://orcid.org/0000-0003-4253-867X)
- Fan Gao (ORCID: https://orcid.org/0000-0002-2828-256X)
- Qiumin Qu
- Shan Wei (ORCID: https://orcid.org/0000-0001-6211-7368)
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Lipids in Health and Disease
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1186/s12944-024-02398-1
- Citations
- 6
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.96
Funders
- Fundamental Research Funds for the Central Universities